Hawkins/$HWKN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Hawkins

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

Ticker

$HWKN
Sector
Primary listing

Employees

1,033

Hawkins Metrics

BasicAdvanced
$2.7B
32.23
$3.97
0.83
$0.73
0.59%

What the Analysts think about Hawkins

Analyst ratings (Buy, Hold, Sell) for Hawkins stock.

Bulls say / Bears say

Hawkins posted record first-quarter fiscal 2026 revenue of $293.3 million, pushing its trailing twelve-month revenue above $1 billion for the first time, highlighting its growing scale.
Water Treatment segment sales rose 21% year-over-year to $150.9 million in Q2 fiscal 2026, driven by organic volume gains and $23 million from acquisitions, lifting segment margins to 29%.
At the close of fiscal 2025, Hawkins reported net debt of $143.9 million and a leverage ratio of 0.86x adjusted EBITDA, leaving ample room for future acquisitions.
Diluted EPS in Q2 fiscal 2026 dropped to $1.08, coming in 13% below consensus expectations of $1.24, signaling margin pressure and possible pricing challenges.
Gross profit for the Food & Health Sciences segment decreased by 4% year-over-year to $15.5 million in Q2 fiscal 2026, highlighting competitive pricing pressures within specialty ingredients markets.
Industrial Solutions segment grew 11% in Q2 fiscal 2026, trailing behind Water Treatment's 21% growth, which increases exposure to revenue concentration risk should industrial demand weaken.
Data summarised monthly by Lightyear AI. Last updated on 1 Nov 2025.

Hawkins Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Hawkins Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HWKN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

FAQs